SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-22-000144
Filing Date
2022-11-30
Accepted
2022-11-30 06:28:44
Documents
10
Period of Report
2022-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k_113022.htm 6-K 12191
2 EX-99.1 interimbusinessreport.htm EX-99.1 26380
3 GRAPHIC interimbusinessreport001.jpg GRAPHIC 145416
4 GRAPHIC interimbusinessreport002.jpg GRAPHIC 246549
5 GRAPHIC interimbusinessreport003.jpg GRAPHIC 272905
6 GRAPHIC interimbusinessreport004.jpg GRAPHIC 334761
7 GRAPHIC interimbusinessreport005.jpg GRAPHIC 413995
8 GRAPHIC interimbusinessreport006.jpg GRAPHIC 360514
9 GRAPHIC interimbusinessreport007.jpg GRAPHIC 224876
10 GRAPHIC interimbusinessreport008.jpg GRAPHIC 189154
  Complete submission text file 0001395064-22-000144.txt   3053975
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 221434263
SIC: 2834 Pharmaceutical Preparations